Virtus ETF Advisers’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,106
| Closed | -$61.2K | – | 591 |
|
|
2024
Q4 | $61.2K | Sell |
2,106
-199
| -9% | -$5.79K | 0.03% | 444 |
|
|
2024
Q3 | $106K | Buy |
2,305
+40
| +2% | +$1.84K | 0.05% | 370 |
|
|
2024
Q2 | $92.5K | Sell |
2,265
-8,524
| -79% | -$348K | 0.05% | 348 |
|
|
2024
Q1 | $275K | Sell |
10,789
-740
| -6% | -$18.9K | 0.15% | 230 |
|
|
2023
Q4 | $104K | Buy |
11,529
+3,416
| +42% | +$30.9K | 0.07% | 341 |
|
|
2023
Q3 | $51.8K | Sell |
8,113
-807
| -9% | -$5.15K | 0.03% | 413 |
|
|
2023
Q2 | $98.9K | Buy |
8,920
+2,989
| +50% | +$33.1K | 0.06% | 387 |
|
|
2023
Q1 | $91K | Sell |
5,931
-2,284
| -28% | -$35.1K | 0.05% | 360 |
|
|
2022
Q4 | $182K | Sell |
8,215
-637
| -7% | -$14.1K | 0.1% | 320 |
|
|
2022
Q3 | $145K | Buy |
8,852
+71
| +0.8% | +$1.16K | 0.06% | 358 |
|
|
2022
Q2 | $128K | Buy |
8,781
+2,495
| +40% | +$36.4K | 0.05% | 359 |
|
|
2022
Q1 | $116K | Sell |
6,286
-378
| -6% | -$6.98K | 0.05% | 276 |
|
|
2021
Q4 | $158K | Sell |
6,664
-1,525
| -19% | -$36.2K | 0.06% | 331 |
|
|
2021
Q3 | $202K | Sell |
8,189
-424
| -5% | -$10.5K | 0.09% | 268 |
|
|
2021
Q2 | $213K | Sell |
8,613
-525
| -6% | -$13K | 0.09% | 300 |
|
|
2021
Q1 | $199K | Buy |
9,138
+166
| +2% | +$3.62K | 0.08% | 330 |
|
|
2020
Q4 | $229K | Buy |
+8,972
| New | +$229K | 0.1% | 330 |
|